Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Winder

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Journal of Internal Medicine|January 22, 2023
Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortalitySylvia Mink, Wolfgang List, Guenter Hoefle, et al.
Journal of Clinical Medicine|June 11, 2020
Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer PatientsMatthias Unseld, Sebastian Fischöder, Mathias Jachs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2014
A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patientsJoanna Szkandera, Martin Pichler, Gudrun Absenger, et al.
Anticancer Research|September 15, 2019
Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic TherapyEwald Wöll, Wolfgang Eisterer, Armin Gerger, et al.
Scientific Reports|March 25, 2021
Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patientsAxel Muendlein, Kathrin Geiger, Stella Gaenger, et al.
Frontiers in Oncology|November 10, 2022
Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patientsAxel Muendlein, Luciano Severgnini, Thomas Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2014
Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patientsAxel Muendlein, Michael Hubalek, Simone Geller-Rhomberg, et al.
Molecular Genetics & Genomic Medicine|September 7, 2019
A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathyJennifer Roggenbuck, Kelly Rich, Ana Morales, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2012
Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancerAxel Muendlein, Alois H Lang, Simone Geller-Rhomberg, et al.
BMC Cancer|January 13, 2018
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II studyAlexander R Siebenhüner, Heike Seifert, Helga Bachmann, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Journal of Internal Medicine|January 22, 2023
Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortalitySylvia Mink, Wolfgang List, Guenter Hoefle, et al.
Journal of Clinical Medicine|June 11, 2020
Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer PatientsMatthias Unseld, Sebastian Fischöder, Mathias Jachs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2014
A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patientsJoanna Szkandera, Martin Pichler, Gudrun Absenger, et al.
Anticancer Research|September 15, 2019
Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic TherapyEwald Wöll, Wolfgang Eisterer, Armin Gerger, et al.
Scientific Reports|March 25, 2021
Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patientsAxel Muendlein, Kathrin Geiger, Stella Gaenger, et al.
Frontiers in Oncology|November 10, 2022
Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patientsAxel Muendlein, Luciano Severgnini, Thomas Decker, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2014
Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patientsAxel Muendlein, Michael Hubalek, Simone Geller-Rhomberg, et al.
Molecular Genetics & Genomic Medicine|September 7, 2019
A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathyJennifer Roggenbuck, Kelly Rich, Ana Morales, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2012
Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancerAxel Muendlein, Alois H Lang, Simone Geller-Rhomberg, et al.
BMC Cancer|January 13, 2018
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II studyAlexander R Siebenhüner, Heike Seifert, Helga Bachmann, et al.
Pageof 10